Bayer Aktiengesellschaft (BAYRY) to Issue Dividend of $0.02 on May 13th

Posted by Patrick Bannon on Apr 27th, 2024

Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) declared a dividend on Wednesday, April 3rd, NASDAQ reports. Stockholders of record on Tuesday, April 30th will be paid a dividend of 0.0191 per share on Monday, May 13th. The ex-dividend date is Monday, April 29th.

Bayer Aktiengesellschaft Stock Up 1.7 %

Shares of BAYRY opened at $7.39 on Friday. Bayer Aktiengesellschaft has a twelve month low of $6.96 and a twelve month high of $16.47. The company has a 50 day moving average of $7.40 and a 200-day moving average of $8.72. The company has a quick ratio of 0.80, a current ratio of 1.27 and a debt-to-equity ratio of 1.15.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) last issued its quarterly earnings results on Tuesday, March 5th. The company reported $0.50 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.12. The company had revenue of $12.77 billion during the quarter. Bayer Aktiengesellschaft had a negative net margin of 6.31% and a positive return on equity of 17.27%. On average, sell-side analysts predict that Bayer Aktiengesellschaft will post 1.36 EPS for the current year.

Wall Street Analysts Forecast Growth

BAYRY has been the subject of several recent analyst reports. Wolfe Research downgraded Bayer Aktiengesellschaft from an “outperform” rating to a “peer perform” rating in a report on Tuesday, January 30th. Sanford C. Bernstein reissued a “market perform” rating on shares of Bayer Aktiengesellschaft in a report on Thursday, March 7th. Finally, Citigroup reissued a “neutral” rating on shares of Bayer Aktiengesellschaft in a report on Thursday, February 29th. One research analyst has rated the stock with a sell rating and eight have given a hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold”.

View Our Latest Stock Analysis on Bayer Aktiengesellschaft

About Bayer Aktiengesellschaft

(Get Free Report)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.